Mark P Mattson Selected Research

Z-1-117

11/2002

p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark P Mattson Research Topics

Disease

106	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2002
58	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2002
37	Stroke (Strokes) 04/2019 - 02/2002
27	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2002
23	Ischemic Stroke 01/2019 - 06/2006
20	Neoplasms (Cancer) 01/2019 - 01/2002
17	Nervous System Diseases (Neurological Disorders) 01/2021 - 03/2003
16	Ischemia 01/2019 - 04/2002
15	Cognitive Dysfunction 01/2020 - 02/2004
15	Insulin Resistance 01/2020 - 04/2002
13	Inflammation (Inflammations) 01/2022 - 03/2007
13	Huntington Disease (Huntington's Disease) 01/2018 - 01/2003
11	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2002
10	Neuroblastoma 01/2021 - 09/2005
10	Obesity 10/2019 - 06/2003
10	Brain Ischemia (Cerebral Ischemia) 06/2018 - 07/2002
10	Body Weight (Weight, Body) 05/2017 - 05/2003
9	Brain Injuries (Brain Injury) 01/2021 - 12/2002
9	Dementia (Dementias) 12/2018 - 10/2002
8	Amyloid Plaque 01/2021 - 12/2002
8	Type 2 Diabetes Mellitus (MODY) 04/2019 - 09/2002
8	Neuroinflammatory Diseases 01/2019 - 07/2007
8	Hypoxia (Hypoxemia) 06/2018 - 04/2002
8	Infarction (Infarctions) 05/2013 - 04/2002
7	Infections 08/2015 - 10/2002
7	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2012 - 10/2002
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 10/2003
5	Seizures (Absence Seizure) 06/2022 - 12/2002
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018 - 07/2002
5	Weight Loss (Weight Reduction) 08/2015 - 05/2002
5	Wounds and Injuries (Trauma) 03/2013 - 01/2003
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2019 - 10/2009
4	Atrophy 11/2017 - 12/2011
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2015 - 07/2007
4	Disease Progression 11/2012 - 03/2003
3	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2006
3	Weight Gain 01/2022 - 05/2014
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 11/2009
3	Premature Aging 11/2019 - 11/2014
3	Hyperglycemia 01/2017 - 03/2003
3	Iron Deficiencies 12/2016 - 09/2008

Drug/Important Bio-Agent (IBA)

54	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2002
39	Amyloid (Amyloid Fibrils)IBA 01/2021 - 03/2002
27	Amyloid beta-PeptidesIBA 01/2021 - 01/2002
26	Peptides (Polypeptides)IBA 01/2019 - 06/2002
23	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 04/2002
20	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2002
17	CalciumIBA 01/2020 - 01/2002
14	EnzymesIBA 01/2019 - 10/2003
13	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2002
13	CytokinesIBA 01/2015 - 12/2004
11	Presenilin-1IBA 01/2021 - 05/2002
9	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2021 - 06/2006
9	HomocysteineIBA 03/2012 - 01/2002
9	Folic Acid (Vitamin M)FDA LinkGeneric 07/2005 - 01/2002
8	SynucleinsIBA 01/2019 - 06/2011
8	Insulin (Novolin)FDA Link 11/2018 - 06/2003
7	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 08/2007
7	LipidsIBA 01/2017 - 02/2004
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2002
7	PresenilinsIBA 06/2007 - 01/2002
6	Hormones (Hormone)IBA 01/2020 - 05/2010
6	NAD (NADH)IBA 10/2019 - 01/2009
6	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2019 - 09/2002
6	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2002
6	LeptinIBA 12/2017 - 06/2003
6	Amino Acids FDA Link 12/2017 - 01/2003
6	Transcription Factors (Transcription Factor)IBA 05/2017 - 09/2003
6	IronIBA 12/2016 - 12/2004
5	Adenosine Triphosphate (ATP)IBA 01/2021 - 04/2002
5	ApolipoproteinsIBA 01/2020 - 07/2006
5	AntioxidantsIBA 11/2015 - 01/2007
5	polyglutamineIBA 12/2011 - 01/2003
5	Glutamic Acid (Glutamate)FDA Link 08/2011 - 07/2002
5	Nerve Growth Factors (Neurotrophins)IBA 02/2011 - 12/2004
5	Glucagon-Like Peptide-1 ReceptorIBA 01/2011 - 01/2009
4	Sirtuin 3IBA 06/2022 - 01/2016
4	Complement System Proteins (Complement)IBA 01/2021 - 08/2007
4	KetonesIBA 01/2020 - 06/2013
4	Apolipoprotein E4IBA 01/2020 - 07/2002
4	Uric Acid (Urate)IBA 01/2019 - 01/2007
4	CarbonIBA 01/2019 - 03/2002
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018 - 08/2007
4	PhytochemicalsIBA 09/2016 - 08/2007
4	UbiquitinIBA 04/2012 - 03/2004
4	Pharmaceutical PreparationsIBA 09/2011 - 12/2004
4	CeramidesIBA 08/2010 - 10/2002
4	Superoxide Dismutase-1IBA 04/2010 - 03/2004
4	Blood Glucose (Blood Sugar)IBA 02/2009 - 09/2002
3	KATP ChannelsIBA 01/2021 - 04/2002
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
3	IncretinsIBA 04/2019 - 06/2010
3	Exenatide (Byetta)FDA Link 01/2019 - 02/2009
3	A-Form DNA (A-DNA)IBA 01/2018 - 10/2014
3	Free RadicalsIBA 01/2017 - 10/2009
3	EstersIBA 01/2017 - 08/2003

Therapy/Procedure

13	Therapeutics 01/2020 - 04/2002
11	Diet Therapy (Therapy, Diet) 09/2013 - 04/2002
8	Caloric Restriction 01/2017 - 02/2003
4	Drug Therapy (Chemotherapy) 01/2022 - 12/2002